Index S&P 500 P/E 29.42 EPS (ttm) 3.16 Insider Own 0.12% Shs Outstand 821.41M Perf Week 2.05%
Market Cap 76.20B Forward P/E 24.20 EPS next Y 3.84 Insider Trans -28.25% Shs Float 819.49M Perf Month 6.27%
Income 2.61B PEG 3.49 EPS next Q 0.87 Inst Own 85.50% Short Float 1.15% Perf Quarter 9.76%
Sales 19.75B P/S 3.86 EPS this Y 9.01% Inst Trans -0.61% Short Ratio 2.16 Perf Half Y 23.96%
Book/sh 0.28 P/B 331.31 EPS next Y 8.99% ROA 15.95% Short Interest 9.42M Perf Year 14.30%
Cash/sh 1.60 P/C 58.17 EPS next 5Y 8.44% ROE 2331.25% 52W Range 67.62 - 93.25 Perf YTD 16.52%
Dividend Est. 2.01 (2.17%) P/FCF 25.21 EPS past 5Y 0.18% ROI 31.15% 52W High -0.39% Beta 0.39
Dividend TTM 1.94 (2.09%) Quick Ratio 0.70 Sales past 5Y 4.62% Gross Margin 59.00% 52W Low 37.36% ATR (14) 1.33
Dividend Ex-Date Jan 19, 2024 Current Ratio 1.06 EPS Y/Y TTM 65.39% Oper. Margin 22.28% RSI (14) 76.17 Volatility 1.74% 1.39%
Employees 34000 Debt/Eq 37.78 Sales Y/Y TTM 7.71% Profit Margin 13.22% Recom 1.83 Target Price 96.71
Option/Short Yes / Yes LT Debt/Eq 35.44 EPS Q/Q 85.18% Payout 68.86% Rel Volume 1.24 Prev Close 92.91
Sales Surprise 2.12% EPS Surprise 5.81% Sales Q/Q 6.18% Earnings Apr 26 BMO Avg Volume 4.37M Price 92.88
SMA20 5.07% SMA50 5.38% SMA200 16.83% Trades
Volume 5,432,689 Change -0.03%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-24 Resumed Goldman
Buy
$93
Jan-29-24 Upgrade Raymond James
Mkt Perform → Outperform
Dec-15-23 Upgrade BofA Securities
Neutral → Buy
$90
Nov-13-23 Initiated Jefferies
Buy
$87
Oct-16-23 Upgrade Stifel
Hold → Buy
$85 → $81
Sep-22-23 Initiated HSBC Securities
Buy
$84
Feb-17-23 Initiated Citigroup
Buy
$84
Jan-30-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$82
Nov-22-22 Initiated Wolfe Research
Peer Perform
Oct-13-22 Upgrade JP Morgan
Neutral → Overweight
$79
Aug-01-22 Upgrade Wells Fargo
Underweight → Equal Weight
$71 → $80
May-03-22 Downgrade Atlantic Equities
Overweight → Neutral
$92 → $80
Apr-08-22 Initiated Raymond James
Mkt Perform
Feb-02-22 Upgrade Bernstein
Underperform → Mkt Perform
$83
Jan-31-22 Reiterated Wells Fargo
Underweight
$78 → $76
Jan-31-22 Reiterated Morgan Stanley
Equal-Weight
$90 → $91
Jan-31-22 Reiterated Deutsche Bank
Buy
$91 → $90
Jan-31-22 Reiterated Credit Suisse
Outperform
$95 → $90
Jan-31-22 Reiterated Citigroup
Neutral
$83 → $86
Dec-16-21 Initiated Redburn
Neutral
Show Previous Ratings
May-03-24 04:07PM
11:02AM
09:40AM
May-01-24 01:41PM
(Investor's Business Daily)
12:09PM
12:45PM
Loading…
Apr-30-24 12:45PM
09:50AM
08:29AM
08:10AM
06:10AM
Apr-29-24 01:10PM
12:28PM
09:39AM
09:35AM
09:24AM
09:15AM
Loading…
09:15AM
08:25AM
08:25AM
07:57AM
07:16AM
06:54AM
06:46AM
Apr-28-24 06:54PM
06:49PM
Apr-27-24 01:01AM
Apr-26-24 10:39PM
(Thomson Reuters StreetEvents)
03:00PM
11:53AM
11:46AM
11:08AM
10:33AM
Loading…
10:33AM
09:32AM
09:30AM
07:42AM
07:25AM
07:04AM
07:02AM
(Associated Press Finance)
07:00AM
06:55AM
06:00AM
Apr-25-24 03:00AM
Apr-24-24 03:02AM
Apr-23-24 02:32PM
12:25PM
09:15AM
07:30AM
Apr-21-24 10:44AM
07:22AM
07:00AM
Apr-19-24 10:00AM
Apr-18-24 08:15AM
07:02AM
Apr-17-24 06:15PM
Apr-16-24 03:02AM
Apr-15-24 07:41AM
Apr-12-24 09:35AM
Apr-11-24 07:37PM
Apr-10-24 12:10PM
Apr-09-24 07:13AM
Apr-05-24 08:48AM
Apr-04-24 09:00AM
Apr-03-24 02:24PM
11:45AM
Apr-02-24 04:12PM
Apr-01-24 09:40AM
Mar-31-24 11:47AM
11:41AM
Mar-30-24 07:34AM
Mar-29-24 12:16PM
Mar-28-24 01:38PM
11:21AM
Mar-27-24 05:04AM
Mar-21-24 10:09AM
Mar-19-24 03:43PM
09:33AM
Mar-18-24 11:45AM
Mar-14-24 04:35PM
Mar-13-24 11:30AM
Mar-12-24 01:08PM
10:43AM
Mar-05-24 04:17PM
Mar-04-24 06:25PM
Mar-01-24 11:35AM
Feb-28-24 09:35AM
04:41AM
Feb-27-24 07:00AM
Feb-26-24 03:33PM
08:07AM
Feb-21-24 02:43PM
(Investor's Business Daily)
Feb-16-24 12:03AM
Feb-15-24 04:30PM
Feb-14-24 11:45AM
Feb-13-24 11:49AM
09:50AM
Feb-12-24 02:02AM
Feb-07-24 09:30AM
Jan-31-24 02:32PM
01:44PM
12:16PM
Jan-30-24 10:46AM
Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill's Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Massey Sally Chief Human Resources Officer May 01 '24 Option Exercise 72.29 6,115 442,053 20,039 May 03 04:04 PM BILBREY JOHN P Director May 01 '24 Option Exercise 62.04 6,329 392,651 36,565 May 03 04:04 PM BILBREY JOHN P Director May 01 '24 Sale 91.59 6,329 579,696 30,236 May 03 04:04 PM Massey Sally Chief Human Resources Officer May 01 '24 Sale 91.92 6,115 562,091 13,924 May 03 04:04 PM Wallace Noel R. Chairman, President & CEO Feb 20 '24 Option Exercise 68.16 55,486 3,781,926 356,829 Feb 20 05:05 PM Wallace Noel R. Chairman, President & CEO Feb 20 '24 Sale 84.22 69,948 5,890,887 286,881 Feb 20 05:05 PM Daniels Jennifer CLO and Secretary Feb 20 '24 Sale 84.67 3,538 299,578 59,698 Feb 20 05:05 PM Parameswaran Prabha Grp Pres, Growth & Strategy Feb 16 '24 Option Exercise 68.16 56,836 3,873,942 75,517 Feb 20 04:22 PM Parameswaran Prabha Grp Pres, Growth & Strategy Feb 16 '24 Sale 84.02 56,836 4,775,378 18,681 Feb 20 04:22 PM Wallace Noel R. Chairman, President & CEO Feb 16 '24 Sale 84.06 29,772 2,502,664 301,343 Feb 20 05:05 PM Daniels Jennifer CLO and Secretary Feb 16 '24 Sale 83.96 5,790 486,108 63,236 Feb 20 05:05 PM Edwards Lisa Director Feb 13 '24 Option Exercise 69.38 2,078 144,172 11,805 Feb 15 04:09 PM Wallace Noel R. Chairman, President & CEO Feb 12 '24 Option Exercise 68.16 50,000 3,408,000 324,179 Feb 14 04:11 PM Wallace Noel R. Chairman, President & CEO Feb 12 '24 Sale 83.15 50,000 4,157,280 274,179 Feb 14 04:11 PM Kooyman John W Chief of Staff Feb 09 '24 Option Exercise 68.16 21,023 1,432,928 26,305 Feb 13 04:11 PM Kooyman John W Chief of Staff Feb 09 '24 Sale 83.60 21,023 1,757,458 5,282 Feb 13 04:11 PM Daniels Jennifer CLO and Secretary Feb 01 '24 Option Exercise 68.16 61,633 4,200,905 119,581 Feb 02 04:10 PM Malcolm Gregory EVP and Controller Feb 01 '24 Option Exercise 68.16 9,821 669,399 16,973 Feb 02 04:09 PM Daniels Jennifer CLO and Secretary Feb 01 '24 Sale 83.93 61,633 5,172,697 57,948 Feb 02 04:10 PM Malcolm Gregory EVP and Controller Feb 01 '24 Sale 85.35 8,930 762,184 8,043 Feb 02 04:09 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Jan 31 '24 Option Exercise 68.16 30,433 2,074,313 42,559 Feb 02 04:09 PM HARRIS C MARTIN Director Jan 31 '24 Option Exercise 62.04 2,760 171,230 22,032 Feb 02 04:09 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Jan 31 '24 Sale 84.41 30,433 2,568,706 12,126 Feb 02 04:09 PM HARRIS C MARTIN Director Jan 31 '24 Sale 84.50 2,760 233,220 19,272 Feb 02 04:09 PM Daniels Jennifer CLO and Secretary Nov 30 '23 Option Exercise 68.16 3,800 259,008 61,993 Dec 04 04:14 PM Daniels Jennifer CLO and Secretary Nov 30 '23 Sale 79.01 3,800 300,219 58,193 Dec 04 04:14 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Nov 28 '23 Option Exercise 68.16 15,000 1,022,400 27,371 Nov 30 04:29 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts Nov 28 '23 Sale 77.83 15,000 1,167,410 12,371 Nov 30 04:29 PM CAHILL JOHN T Director Nov 03 '23 Option Exercise 62.04 6,329 392,651 31,015 Nov 07 04:15 PM CAHILL JOHN T Director Nov 03 '23 Sale 74.92 6,329 474,170 24,686 Nov 07 04:15 PM Kooyman John W Chief of Staff Nov 03 '23 Sale 75.11 3,000 225,330 5,347 Nov 07 04:14 PM NORRINGTON LORRIE M Director Nov 02 '23 Option Exercise 62.04 6,329 392,651 37,636 Nov 06 04:22 PM NORRINGTON LORRIE M Director Nov 02 '23 Sale 74.56 6,329 471,919 31,307 Nov 06 04:22 PM Wallace Noel R. Chairman, President & CEO Sep 11 '23 Option Exercise 73.00 48,627 3,549,771 295,596 Sep 13 04:04 PM Daniels Jennifer CLO and Secretary Sep 11 '23 Option Exercise 73.00 24,704 1,803,392 77,517 Sep 13 04:05 PM Wallace Noel R. Chairman, President & CEO Sep 11 '23 Sale 73.37 48,627 3,567,982 246,969 Sep 13 04:04 PM Daniels Jennifer CLO and Secretary Sep 11 '23 Sale 73.31 24,704 1,811,016 52,813 Sep 13 04:05 PM Malcolm Gregory Vice President and Controller Aug 31 '23 Option Exercise 73.00 10,493 765,989 18,345 Sep 01 04:03 PM Malcolm Gregory Vice President and Controller Aug 31 '23 Sale 73.90 10,493 775,457 7,852 Sep 01 04:03 PM Malcolm Gregory Vice President and Controller Aug 30 '23 Sale 73.85 1,365 100,805 7,852 Sep 01 04:03 PM Kooyman John W Chief of Staff Aug 02 '23 Option Exercise 73.00 21,677 1,582,421 28,061 Aug 04 04:05 PM Kooyman John W Chief of Staff Aug 02 '23 Sale 77.69 21,677 1,684,062 6,384 Aug 04 04:05 PM Daniels Jennifer CLO and Secretary May 19 '23 Option Exercise 73.00 24,703 1,803,319 77,472 May 23 04:10 PM Daniels Jennifer CLO and Secretary May 19 '23 Sale 79.70 24,703 1,968,930 52,769 May 23 04:10 PM Massey Sally Chief Human Resources Officer May 15 '23 Option Exercise 73.00 14,594 1,065,362 23,209 May 17 04:07 PM Massey Sally Chief Human Resources Officer May 15 '23 Sale 81.55 14,594 1,190,141 8,615 May 17 04:07 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 10 '23 Option Exercise 73.00 13,698 999,954 20,604 May 12 04:10 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 10 '23 Sale 81.08 13,698 1,110,579 6,906 May 12 04:10 PM Tsourapas Panagiotis Grp Pres, Eur& Developing Mkts May 10 '23 Sale 81.01 2,404 194,739 822 May 12 04:10 PM BILBREY JOHN P Director May 09 '23 Option Exercise 71.65 5,703 408,620 31,960 May 10 04:23 PM BILBREY JOHN P Director May 09 '23 Sale 80.81 5,703 460,869 26,257 May 10 04:23 PM Parameswaran Prabha Grp Pres, Growth & Strategy May 08 '23 Option Exercise 73.00 64,373 4,699,229 76,800 May 10 04:21 PM Wallace Noel R. Chairman, President & CEO May 08 '23 Option Exercise 73.00 50,000 3,650,000 296,619 May 10 04:21 PM Parameswaran Prabha Grp Pres, Growth & Strategy May 08 '23 Sale 80.58 64,373 5,187,170 12,427 May 10 04:21 PM Wallace Noel R. Chairman, President & CEO May 08 '23 Sale 80.66 50,000 4,032,920 246,619 May 10 04:21 PM
Index - P/E - EPS (ttm) -2.50 Insider Own 0.97% Shs Outstand 492.85M Perf Week 2.04%
Market Cap 6.69B Forward P/E 12.79 EPS next Y 1.06 Insider Trans 0.80% Shs Float 489.28M Perf Month -12.65%
Income -1231.00M PEG - EPS next Q 0.26 Inst Own 97.92% Short Float 3.17% Perf Quarter -8.15%
Sales 4.42B P/S 1.51 EPS this Y 3.25% Inst Trans -3.01% Short Ratio 3.73 Perf Half Y 56.78%
Book/sh 12.63 P/B 1.07 EPS next Y 15.11% ROA -8.25% Short Interest 15.52M Perf Year 48.03%
Cash/sh 0.71 P/C 18.99 EPS next 5Y 8.87% ROE -18.22% 52W Range 7.88 - 16.88 Perf YTD -9.19%
Dividend Est. - P/FCF 51.03 EPS past 5Y - ROI -10.20% 52W High -19.85% Beta 1.39
Dividend TTM - Quick Ratio 1.35 Sales past 5Y 9.00% Gross Margin 43.88% 52W Low 71.70% ATR (14) 0.48
Dividend Ex-Date - Current Ratio 2.75 EPS Y/Y TTM -1484.90% Oper. Margin 7.38% RSI (14) 41.33 Volatility 3.30% 3.46%
Employees 9800 Debt/Eq 0.95 Sales Y/Y TTM -0.02% Profit Margin -27.87% Recom 2.00 Target Price 17.75
Option/Short Yes / Yes LT Debt/Eq 0.94 EPS Q/Q -158.91% Payout - Rel Volume 0.89 Prev Close 13.47
Sales Surprise 3.33% EPS Surprise -23.44% Sales Q/Q 4.76% Earnings May 08 BMO Avg Volume 4.16M Price 13.53
SMA20 -2.29% SMA50 -10.59% SMA200 3.21% Trades
Volume 3,719,970 Change 0.45%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-05-24 Upgrade Stifel
Hold → Buy
$13 → $20
Dec-19-23 Initiated Jefferies
Buy
$17
Dec-15-23 Upgrade Morgan Stanley
Equal-Weight → Overweight
$16
Dec-07-23 Initiated Exane BNP Paribas
Outperform
$18
Apr-20-23 Upgrade Barclays
Equal Weight → Overweight
$14
Aug-18-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$37 → $22
Aug-16-22 Downgrade JP Morgan
Overweight → Neutral
$28 → $24
Jul-21-22 Downgrade Goldman
Buy → Sell
$32 → $19
Jul-12-22 Initiated Piper Sandler
Neutral
$22
Nov-18-21 Initiated Morgan Stanley
Overweight
$40
Oct-28-21 Downgrade Stifel
Buy → Hold
$37 → $34
Aug-05-21 Resumed Credit Suisse
Outperform
$38
Jun-15-21 Upgrade Cleveland Research
Underperform → Neutral
May-11-21 Upgrade Gabelli & Co
Hold → Buy
May-11-21 Upgrade Barclays
Underweight → Equal Weight
$25 → $29
Apr-15-21 Initiated Stifel
Buy
$37
Mar-22-21 Downgrade Gabelli & Co
Buy → Hold
Feb-26-21 Upgrade Credit Suisse
Neutral → Outperform
$33 → $38
Dec-09-20 Downgrade Argus
Buy → Hold
Nov-09-20 Downgrade Barclays
Overweight → Underweight
$35 → $25
Show Previous Ratings
Apr-25-24 11:27AM
Apr-23-24 08:30AM
Apr-21-24 10:39AM
Apr-17-24 08:00AM
Apr-01-24 07:00AM
06:39AM
Loading…
06:39AM
06:30AM
Mar-31-24 11:37PM
Mar-13-24 02:21PM
Mar-12-24 07:00PM
Mar-05-24 10:15AM
Mar-04-24 08:33AM
Feb-29-24 03:30PM
01:08PM
08:00AM
07:03AM
Loading…
07:03AM
Feb-28-24 10:58AM
Feb-26-24 11:41PM
(Thomson Reuters StreetEvents)
02:15PM
09:30AM
06:52AM
06:27AM
Feb-22-24 08:00AM
Feb-21-24 09:15AM
Feb-19-24 10:00AM
Feb-15-24 07:00AM
Feb-13-24 01:09PM
Feb-09-24 10:15AM
Feb-08-24 02:46PM
08:00AM
01:25PM
Loading…
Feb-07-24 01:25PM
Feb-05-24 07:01AM
(The Wall Street Journal) +7.94%
06:48AM
06:36AM
06:33AM
06:33AM
Jan-18-24 08:22PM
Jan-17-24 08:30AM
Jan-08-24 07:35AM
Jan-02-24 08:33AM
Jan-01-24 09:15AM
Dec-19-23 08:00AM
Dec-14-23 05:08PM
Dec-08-23 09:00AM
Dec-07-23 04:37PM
Nov-27-23 08:00AM
Nov-10-23 05:20PM
Nov-09-23 03:49AM
Nov-08-23 04:03PM
12:21AM
(Thomson Reuters StreetEvents)
Nov-07-23 01:45PM
09:30AM
07:31AM
07:03AM
06:33AM
Nov-02-23 11:33AM
08:00AM
07:16AM
Nov-01-23 09:00AM
Oct-30-23 04:32PM
Oct-17-23 04:57PM
08:00AM
Oct-09-23 09:55AM
Oct-06-23 12:05PM
08:36AM
Oct-05-23 11:22AM
Oct-04-23 06:30AM
Sep-19-23 06:20AM
04:23AM
Sep-12-23 06:40AM
Sep-07-23 04:15PM
Sep-05-23 05:00PM
Aug-09-23 10:36AM
07:56AM
Aug-08-23 12:16AM
(Thomson Reuters StreetEvents)
Aug-07-23 02:30PM
12:34PM
09:30AM
07:50AM
06:33AM
Aug-02-23 07:10AM
06:55AM
Market Digest: CCI, CCI, ASH, ITW, MAR, MDC, SHEL, SANM, LEA, ANET, ELAN
(Argus Research)
Jul-20-23 08:00AM
Jul-18-23 08:00AM
Jul-17-23 08:48AM
Jul-14-23 06:29PM
12:21PM
Jul-13-23 06:30PM
05:24PM
Jul-01-23 09:21AM
Jun-24-23 03:19PM
Jun-05-23 08:00AM
May-30-23 06:20PM
May-25-23 08:00AM
May-16-23 11:13AM
May-09-23 06:30PM
11:25AM
07:55AM
06:34AM
May-08-23 05:45PM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
DOYLE WILLIAM F Director Mar 08 '24 Buy 16.30 15,000 244,500 61,330 Mar 12 04:32 PM Harrington Michael J Director Mar 08 '24 Buy 16.29 3,100 50,494 77,594 Mar 12 04:30 PM HOOVER R DAVID Director Mar 06 '24 Buy 16.14 20,000 322,808 185,000 Mar 08 05:09 PM
Index S&P 500 P/E 9.91 EPS (ttm) 3.96 Insider Own 0.35% Shs Outstand 229.37M Perf Week -2.02%
Market Cap 9.00B Forward P/E 8.60 EPS next Y 4.56 Insider Trans 0.00% Shs Float 228.57M Perf Month -8.81%
Income 928.10M PEG 0.90 EPS next Q 0.68 Inst Own 91.95% Short Float 2.69% Perf Quarter -1.92%
Sales 6.73B P/S 1.34 EPS this Y 9.05% Inst Trans 3.72% Short Ratio 1.52 Perf Half Y 47.57%
Book/sh 11.59 P/B 3.38 EPS next Y 7.81% ROA 8.81% Short Interest 6.16M Perf Year 0.72%
Cash/sh 32.53 P/C 1.21 EPS next 5Y 11.00% ROE 37.33% 52W Range 25.99 - 48.80 Perf YTD 6.60%
Dividend Est. 1.38 (3.53%) P/FCF 6.95 EPS past 5Y 23.01% ROI 7.95% 52W High -19.59% Beta 1.62
Dividend TTM 1.35 (3.44%) Quick Ratio 5.68 Sales past 5Y 3.32% Gross Margin 72.52% 52W Low 50.98% ATR (14) 1.13
Dividend Ex-Date Mar 07, 2024 Current Ratio 6.25 EPS Y/Y TTM 17.74% Oper. Margin 21.22% RSI (14) 36.15 Volatility 2.39% 2.45%
Employees 18500 Debt/Eq 3.51 Sales Y/Y TTM 2.01% Profit Margin 13.80% Recom 1.91 Target Price 50.02
Option/Short Yes / Yes LT Debt/Eq 3.39 EPS Q/Q 2.59% Payout 30.94% Rel Volume 0.80 Prev Close 38.79
Sales Surprise 1.45% EPS Surprise 11.13% Sales Q/Q 2.92% Earnings May 09 BMO Avg Volume 4.04M Price 39.24
SMA20 -3.69% SMA50 -11.78% SMA200 6.29% Trades
Volume 3,247,765 Change 1.16%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-06-24 Reiterated Telsey Advisory Group
Outperform
$49 → $54
Feb-29-24 Downgrade Jefferies
Buy → Hold
$50
Feb-05-24 Upgrade Evercore ISI
In-line → Outperform
$30 → $50
Dec-12-23 Resumed Morgan Stanley
Equal-Weight
$38
Nov-07-23 Initiated Evercore ISI
In-line
$30
Sep-13-23 Downgrade Redburn Atlantic
Overweight → Neutral
$33
Aug-01-23 Upgrade Barclays
Equal Weight → Overweight
$47 → $59
May-15-23 Upgrade Bernstein
Mkt Perform → Outperform
$50 → $55
Jan-23-23 Downgrade Barclays
Overweight → Equal Weight
$43
Jan-05-23 Downgrade Bernstein
Outperform → Mkt Perform
Dec-20-22 Initiated Raymond James
Outperform
$44
Dec-12-22 Upgrade Goldman
Neutral → Buy
$37 → $44
Jun-15-22 Upgrade Jefferies
Hold → Buy
$30 → $45
Mar-15-22 Initiated Bernstein
Outperform
$62
Jan-28-22 Upgrade Citigroup
Neutral → Buy
$50 → $48
Nov-19-21 Upgrade Argus
Hold → Buy
$54
Jul-14-21 Initiated Goldman
Neutral
$42
May-07-21 Upgrade BTIG Research
Neutral → Buy
$65
Feb-22-21 Upgrade Credit Suisse
Neutral → Outperform
$39 → $50
Feb-09-21 Upgrade Telsey Advisory Group
Market Perform → Outperform
$38 → $46
Show Previous Ratings
May-02-24 10:01AM
08:45AM
07:00AM
Apr-30-24 02:37PM
10:54AM
08:45AM
Loading…
08:45AM
Apr-29-24 12:01AM
Apr-26-24 08:45AM
Apr-25-24 06:45AM
02:00AM
Apr-24-24 01:58PM
Apr-23-24 05:55PM
05:18PM
12:59PM
11:53AM
(The Wall Street Journal)
11:53AM
Loading…
11:53AM
(The Wall Street Journal)
10:31AM
(The Wall Street Journal)
09:05AM
08:55AM
06:29AM
Apr-22-24 06:21PM
(Associated Press Finance)
05:46PM
(The Wall Street Journal)
05:38PM
05:29PM
05:12PM
(The Wall Street Journal)
05:10PM
04:59PM
12:02PM
Apr-20-24 07:00AM
(The Wall Street Journal)
Apr-19-24 09:00AM
07:47PM
Loading…
Apr-17-24 07:47PM
07:44AM
Apr-16-24 05:48AM
Apr-15-24 12:29PM
12:04PM
10:58AM
Apr-12-24 10:45AM
Apr-09-24 04:32PM
Apr-05-24 09:40AM
Apr-04-24 03:33PM
08:00AM
Apr-03-24 06:43PM
01:33PM
11:42AM
10:43AM
Apr-02-24 11:45AM
(The Wall Street Journal)
Apr-01-24 07:22AM
Mar-29-24 01:30PM
Mar-28-24 03:24PM
01:15PM
09:40AM
Mar-27-24 10:43AM
Mar-22-24 09:40AM
Mar-20-24 09:40AM
Mar-19-24 01:46PM
Mar-08-24 04:20AM
Mar-07-24 09:00AM
Mar-06-24 12:21PM
09:40AM
Mar-04-24 11:59AM
Feb-29-24 06:45AM
Feb-28-24 09:50AM
Feb-23-24 03:33AM
Feb-22-24 02:00PM
Feb-21-24 06:02AM
Feb-20-24 01:03PM
Feb-15-24 09:00AM
Feb-14-24 11:10AM
Feb-13-24 12:00PM
08:02AM
Feb-12-24 07:43PM
05:24PM
06:40AM
Feb-09-24 05:09PM
11:45AM
11:08AM
06:53AM
12:59AM
Feb-08-24 10:26PM
(Thomson Reuters StreetEvents) +6.54%
05:48PM
05:01PM
02:13PM
12:00PM
11:53AM
10:54AM
09:30AM
07:55AM
07:32AM
07:32AM
07:13AM
07:10AM
07:03AM
07:02AM
07:00AM
(Associated Press Finance)
06:53AM
06:49AM
06:45AM
Feb-07-24 02:00PM
12:01AM
Feb-06-24 06:56PM
(Investor's Business Daily)
Tapestry, Inc. engages in the provision of luxury accessories and lifestyle brands. It operates through the following segments: Coach, Kate Spade, and Stuart Weitzman. The Coach segment consists of global sales of Coach brand products to customers through Coach operated stores, including the internet and concession shop-in-shops, and sales to wholesale customers, and through independent third-party distributors. The Kate Spade segment focuses on Kate Spade New York brand products to customers through Kate Spade operated stores, including the Internet, sales to wholesale customers, through concession shop-in-shops and through independent third-party distributors. The Stuart Weitzman segment includes Stuart Weitzman brand products primarily through Stuart Weitzman operated stores. The company was founded by Dawn Hughes in 1941 and is headquartered in New York, NY.
Index - P/E 22.42 EPS (ttm) 0.07 Insider Own 80.30% Shs Outstand 660.73M Perf Week 20.15%
Market Cap 1.06B Forward P/E 9.44 EPS next Y 0.17 Insider Trans 0.00% Shs Float 130.30M Perf Month -8.52%
Income 48.37M PEG - EPS next Q 0.03 Inst Own 17.63% Short Float 6.25% Perf Quarter -31.78%
Sales 443.42M P/S 2.40 EPS this Y -10.53% Inst Trans -1.59% Short Ratio 3.68 Perf Half Y 18.38%
Book/sh 1.29 P/B 1.24 EPS next Y 19.17% ROA 2.78% Short Interest 8.14M Perf Year -56.01%
Cash/sh 0.77 P/C 2.10 EPS next 5Y - ROE 5.82% 52W Range 1.19 - 4.26 Perf YTD -36.61%
Dividend Est. - P/FCF 6.18 EPS past 5Y -0.81% ROI 3.22% 52W High -62.25% Beta 2.34
Dividend TTM - Quick Ratio 9.12 Sales past 5Y 46.30% Gross Margin 60.15% 52W Low 35.29% ATR (14) 0.12
Dividend Ex-Date - Current Ratio 10.71 EPS Y/Y TTM -76.43% Oper. Margin 20.81% RSI (14) 55.83 Volatility 8.32% 7.96%
Employees 233 Debt/Eq 0.76 Sales Y/Y TTM -29.82% Profit Margin 10.91% Recom 3.00 Target Price 2.36
Option/Short Yes / Yes LT Debt/Eq 0.76 EPS Q/Q -61.89% Payout 0.00% Rel Volume 0.69 Prev Close 1.64
Sales Surprise 3.95% EPS Surprise 7.53% Sales Q/Q -13.08% Earnings May 02 BMO Avg Volume 2.21M Price 1.61
SMA20 13.34% SMA50 -4.09% SMA200 -25.68% Trades
Volume 1,534,195 Change -1.83%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-19-24 Upgrade Piper Sandler
Underweight → Neutral
$1.25 → $2
Oct-04-23 Upgrade Barclays
Underweight → Equal Weight
Aug-25-23 Downgrade Piper Sandler
Neutral → Underweight
$3 → $2
Aug-11-23 Downgrade Canaccord Genuity
Buy → Hold
$5 → $3
Aug-09-23 Downgrade Telsey Advisory Group
Outperform → Market Perform
$6 → $4
Mar-16-23 Downgrade TD Cowen
Outperform → Market Perform
$10 → $4.50
Mar-01-23 Downgrade Goldman
Buy → Neutral
$6
Nov-17-22 Initiated Canaccord Genuity
Buy
$8
Oct-19-22 Downgrade Raymond James
Strong Buy → Mkt Perform
Oct-19-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$13 → $6.50
Oct-19-22 Downgrade JP Morgan
Overweight → Underweight
$16 → $8
Oct-19-22 Downgrade Jefferies
Buy → Hold
$18 → $6
Oct-19-22 Downgrade Evercore ISI
Outperform → In-line
$40 → $10
Oct-19-22 Downgrade BofA Securities
Buy → Underperform
$15 → $5
Oct-19-22 Downgrade Barclays
Equal Weight → Underweight
$5
Sep-29-22 Downgrade Piper Sandler
Overweight → Neutral
$19 → $12
Aug-03-22 Downgrade Barclays
Overweight → Equal Weight
$16
Mar-09-22 Upgrade Barclays
Equal Weight → Overweight
$29 → $17
Feb-23-22 Upgrade Jefferies
Hold → Buy
$25
Nov-08-21 Upgrade Morgan Stanley
Equal-Weight → Overweight
$31
Show Previous Ratings
May-03-24 09:30AM
03:34AM
May-02-24 10:53AM
09:52AM
09:30AM
07:30AM
Loading…
07:30AM
06:48AM
06:45AM
May-01-24 03:15AM
Apr-25-24 10:02AM
Apr-18-24 07:45AM
Apr-05-24 11:59AM
Apr-04-24 05:20PM
Mar-25-24 01:57PM
Mar-01-24 09:57AM
01:40AM
Loading…
01:40AM
(Thomson Reuters StreetEvents)
Feb-29-24 12:28PM
12:14PM
09:30AM
08:53AM
07:55AM
07:00AM
06:45AM
Feb-28-24 02:02AM
Feb-27-24 06:45AM
Feb-26-24 09:16AM
Feb-22-24 10:00AM
Feb-15-24 06:45AM
Feb-06-24 09:21AM
Jan-29-24 04:53AM
02:22AM
Loading…
Jan-26-24 02:22AM
Jan-25-24 03:37AM
Jan-24-24 05:37AM
Jan-23-24 05:23AM
Jan-22-24 04:12AM
Jan-16-24 02:39AM
Jan-11-24 04:30AM
Jan-10-24 07:44AM
Dec-30-23 08:49AM
Dec-06-23 11:55AM
Nov-22-23 06:45AM
Nov-08-23 04:57PM
Nov-07-23 09:36AM
09:30AM
06:45AM
06:32AM
Oct-31-23 10:01AM
Oct-24-23 06:45AM
Oct-12-23 08:00AM
Oct-05-23 02:30AM
Sep-06-23 08:30AM
Aug-28-23 09:07AM
Aug-25-23 09:42AM
Aug-24-23 06:45AM
Aug-11-23 09:55AM
Aug-09-23 12:11AM
(Thomson Reuters StreetEvents) -13.31%
Aug-08-23 12:33PM
10:32AM
10:00AM
09:51AM
08:05AM
06:45AM
Jul-31-23 11:58PM
Jul-25-23 06:45AM
Jul-11-23 08:00AM
Jun-28-23 07:00AM
Jun-16-23 08:21AM
Jun-12-23 07:11AM
May-25-23 08:01AM
May-22-23 08:11AM
May-21-23 07:45AM
May-15-23 08:30AM
May-10-23 01:46AM
(Thomson Reuters StreetEvents)
May-09-23 08:05AM
06:45AM
May-08-23 06:45AM
May-05-23 02:24PM
08:31AM
Apr-28-23 02:34AM
Apr-25-23 04:05PM
Apr-16-23 09:15AM
Apr-12-23 08:32AM
Apr-06-23 12:04PM
(The Wall Street Journal)
Mar-31-23 07:05AM
05:19AM
Mar-29-23 07:33AM
Mar-23-23 06:40AM
Mar-09-23 09:19AM
Mar-02-23 03:18PM
05:19AM
Mar-01-23 02:26AM
(Thomson Reuters StreetEvents) -6.91%
Feb-28-23 12:59PM
10:43AM
09:52AM
09:16AM
08:17AM
08:05AM
06:45AM
Feb-27-23 06:45AM
Feb-24-23 06:27AM
Olaplex Holdings, Inc. is a science-enabled, technology-driven beauty company, focused on delivering its patent-protected hair care products to professional hair salons, retailers, and everyday consumers. The brand OLAPLEX is a patent-protected, proven, and potent haircare technology system that restores all hair types to its healthiest state possible. OLAPLEX created the Bond Building category which protects, strengthens, and rebuilds broken bonds in the hair during and after hair services. The company was founded in 2014 and is headquartered in Santa Barbara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BILBREY JOHN P Director Sep 15 '23 Buy 2.29 8,100 18,549 58,100 Sep 18 05:16 PM BILBREY JOHN P Director Aug 15 '23 Buy 2.63 43,500 114,405 50,000 Aug 15 04:10 PM BILBREY JOHN P Director Aug 14 '23 Buy 2.65 6,500 17,225 6,500 Aug 15 04:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
